Rigosertib is a more effective radiosensitizer than cisplatin in concurrent chemoradiation treatment of cervical carcinoma, in vitro and in vivo

  • Lorenzo Agoni
  • , Indranil Basu
  • , Seema Gupta
  • , Alan Alfieri
  • , Angela Gambino
  • , Gary L. Goldberg
  • , E. Premkumar Reddy
  • , Chandan Guha

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'Rigosertib is a more effective radiosensitizer than cisplatin in concurrent chemoradiation treatment of cervical carcinoma, in vitro and in vivo'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science